Reading, United Kingdom

Ruth Harper

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Ruth Harper: Pioneering Treatments for Diabetes

Introduction: Ruth Harper, an accomplished inventor based in Reading, GB, has made significant strides in the medical field through her innovative contributions in diabetes treatment. With three patents to her name, Harper is at the forefront of addressing patient needs, particularly for those unable to tolerate traditional metformin therapy.

Latest Patents: Among her notable inventions, one of the latest patents focuses on the treatment for diabetes in patients who are inappropriate for metformin therapy. The invention highlights the use of certain DPP-4 inhibitors, recognized for their potential in treating and preventing metabolic diseases, especially in patients where metformin is not an option due to intolerability or contraindications.

Career Highlights: Ruth Harper has leveraged her expertise to propel advancements in diabetes management, significantly impacting patient care. Her work with Boehringer Ingelheim International GmbH has allowed her to collaborate with leading professionals in the field, contributing to cutting-edge research and development.

Collaborations: Throughout her career, Harper has had the opportunity to work alongside esteemed colleagues, including Klaus Dugi and Eva Ulrike Graefe-Mody. These collaborations have enriched her research efforts and have been instrumental in the development of her patented innovations.

Conclusion: Ruth Harper's commitment to innovation in the medical sector has led to remarkable advancements in the treatment of diabetes. Her work exemplifies the importance of addressing diverse patient needs through targeted therapies, paving the way for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…